» Authors » Tibor Hlavaty

Tibor Hlavaty

Explore the profile of Tibor Hlavaty including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 1028
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jalali Y, Gojdicova A, Sturdik I, Toth J, Koller T, Huorka M, et al.
Bratisl Lek Listy . 2023 May; 124(7):485-492. PMID: 37218475
Background: Despite long-term use of infliximab (IFX) in IBD treatment, its optimized use is unclear due to its complicated pharmacokinetics/dynamics. Hence, the predictive value of IFX trough levels (TL) is...
2.
Bokemeyer B, Hlavaty T, Allez M, Selema P, Moosavi S, Cadatal M, et al.
Expert Opin Biol Ther . 2023 Apr; 23(8):791-800. PMID: 37038897
Background: The objective of this non-interventional, observational prospective cohort study (CONNECT-IBD) was to assess the use of CT-P13 (Inflectra®) in the treatment of patients with Crohn's disease (CD) and ulcerative...
3.
Vrablicova Z, Tomova K, Tothova L, Babickova J, Gromova B, Konecna B, et al.
Front Med (Lausanne) . 2020 Dec; 7:593316. PMID: 33381513
The role of cell-free DNA (cfDNA) in the pathogenesis of inflammatory bowel disease (IBD) has been recently suggested. The aim of this study was to analyze circulating cfDNA and deoxyribonuclease...
4.
Soltys K, Stuchlikova M, Hlavaty T, Gaalova B, Budis J, Gazdarica J, et al.
Sci Rep . 2020 Apr; 10(1):6024. PMID: 32265456
Higher probability of the development of Crohn's disease (CD) and ulcerative colitis (UC) as a possible consequence of the north-south gradient has been recently suggested. Living far north or south...
5.
Adamina M, Bonovas S, Raine T, Spinelli A, Warusavitarne J, Armuzzi A, et al.
J Crohns Colitis . 2019 Nov; 14(2):155-168. PMID: 31742338
This article is the second in a series of two publications relating to the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's disease. The first...
6.
Torres J, Bonovas S, Doherty G, Kucharzik T, Gisbert J, Raine T, et al.
J Crohns Colitis . 2019 Nov; 14(1):4-22. PMID: 31711158
No abstract available.
7.
Krajcovicova A, Kuzma M, Hlavaty T, Hans D, Koller T, Jackuliak P, et al.
Eur J Gastroenterol Hepatol . 2017 Oct; 30(1):101-106. PMID: 29064848
Objectives: Osteoporosis and osteopaenia are known chronic complications of inflammatory bowel diseases. The trabecular bone score (TBS) provides an indirect measurement of bone microarchitecture, independent of bone mineral density (BMD)....
8.
Koller T, Galambosova M, Filakovska S, Kubincova M, Hlavaty T, Toth J, et al.
World J Gastroenterol . 2017 Jun; 23(22):4102-4111. PMID: 28652663
Aim: To analyze 1-year liver injury burden in inflammatory bowel disease (IBD) patients. Methods: During a 6-mo inclusion period, consecutive IBD cases having a control visit at IBD center were...
9.
Sturdik I, Kuzma M, Kuzmova Z, Koller T, Javorka V, Hlavaty T, et al.
Vnitr Lek . 2016 Dec; 62(10):833-836. PMID: 27900870
Hemosuccus pancreaticus is a rare cause of upper digestive tract bleeding, it is hemorrhage to the pancreatic duct. A case report is about 56-years old man who was repeatedly hospitalized...
10.
Koller T, Piestanska Z, Hlavaty T, Holoman J, Glasa J, Payer J
Vnitr Lek . 2016 Jun; 62(5):351-9. PMID: 27319227
Introduction And Objectives: Hepatic transit times measured by the contrast enhanced ultrasonography and liver elasticity were found to predict a clinically significant portal hypertension. However, these modalities we not yet...